HempFusion® has announced the launch of its Food and Drug Administration listed CBD Over-the-Counter Topicals Products featuring scientifically documented active ingredients targeting specific consumer needs including menthol, salicylic acid, and colloidal oatmeal, providing relief for pain, acne, eczema and more.
HempFusion is a dietary supplements company focused on products that contain Hemp/CBD in the United States with distribution of its family of brands to approximately 4,000 retailers across 47 states. The company has a wide variety of 25+ CBD products with a full spectrum of cannabinoids and other constituents are sourced from quality phytocompounds manufactured under cGMP standards designed to attain efficacy and safety.
The new range includes aloe vera, jojoba oil, shea butter, essential oils and HempFusion’s premium panoramic full-spectrum hemp extract featuring CBD and other naturally occurring cannabinoids as well as terpenes for their skin conditioning and moisturizing benefits.
“With the launch of our innovative OTC CBD Topicals line, HempFusion provides consumers with high quality OTC products that are backed by science“, stated Jason Mitchell, N.D., Co-CEO of HempFusion. “By producing and marketing these products in accordance with the FDA’s OTC regulations, we are able to utilize active ingredients that target specific conditions for a variety of consumer needs, which we believe has the ability to substantially increase our customer base“, continued Mitchell.
“We believe these new product offerings will increase our customer base by providing concerned retailers with the ability to stock our OTC CBD Topicals with confidence that these products follow the FDA’s OTC guidelines,” added Ian deQueiroz Co-CEO of HempFusion. “We anticipate this specialized line has the potential to be a significant revenue driver and division of the Company,” continued deQueiroz.
Source | Hemp Fusion